Translational Medicine in Pulmonary-Renal Crosstalk: Therapeutic Targeting of p-Cresyl Sulfate Triggered Nonspecific ROS and Chemoattractants in Dyspneic Patients with Uremic Lung Injury
Authors:
- Jia-Feng ChangJCJia-Feng Chang
- Shih-Shin LiangSLShih-Shin Liang
- Pounraj ThanasekaranPounraj Thanasekaran
- Hsueh-Wei ChangHCHsueh-Wei Chang
- Li-Li WenLWLi-Li Wen
- Chung-Hua ChenCCChung-Hua Chen
- Jian-Chiun LiouJLJian-Chiun Liou
- Jih-Chen YehJYJih-Chen Yeh
- Shih-Hao LiuSLShih-Hao Liu
- Huei-Min DaiHDHuei-Min Dai
- Wei-Ning LinWLWei-Ning Lin
Open Access
- 9 September 2018
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 7 (9) , 266
Abstract
Molecular mechanisms and pathological features of p-Cresyl sulfate (PCS)-induced uremic lung injury (ULI) in chronic kidney disease (CKD) remain unclear. We analyzed pleural effusions (PE) from CKD and non-CKD patients for uremic toxins, reactive oxygen species (ROS), and chemotactic cytokines. Correlations between PE biomarkers and serum creatinine were also studied. Cell viability and inflammatory signaling pathways were investigated in PCS-treated human alveolar cell model. To mimic human diseases, CKD-ULI mouse model was developed with quantitative comparison of immunostaining and morphometric approach. PE from CKD patients enhance expressions of uremic toxins, hydroxyl radicals, and IL-5/IL-6/IL-8/IL-10/IL-13/ENA-78/GRO α/MDC/thrombopoietin/VEGF. PE concentrations of ENA-78/VEGF/IL-8/MDC/PCS/indoxyl sulphate correlate with serum creatinine concentrations. In vitro, PCS promotes alveolar cell death, cPLA2/COX-2/aquaporin-4 expression, and NADPH oxidase/mitochondria activation-related ROS. Intracellular ROS is abrogated by non-specific ROS scavenger N-acetyl cysteine (NAC), inhibitors of NADPH oxidase and mitochondria-targeted superoxide scavenger. However, only NAC protects against PCS-induced cell death. In vivo, expressions of cPLA2/COX2/8-OHdG, resident alveolar macrophages, recruited leukocytes, alveolar space, interstitial edema and capillary leakage increase in lung tissues of CKD-ULI mice, and NAC pretreatment ameliorates alveolar–capillary injury. PCS causes alveolar–capillary injury through triggering intracellular ROS, downstream prostaglandin pathways, cell death, and activating leukocytes to release multiplex chemoattractants and extracellular ROS. Thus PCS and nonspecific ROS serve as potential therapeutic targets.Keywords
Funding Information
- Fu Jen Catholic University Research Foundation (410031034022 and A0103017)
- Ministry of Science and Technology (106-2221-E-151-051-)
- En Chu Kong Hospital (ECKH10505)
This publication has 30 references indexed in Scilit:
- AdipoR-increased intracellular ROS promotes cPLA2and COX-2 expressions via activation of PKC and p300 in adiponectin-stimulated human alveolar type II cellsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2016
- Impact of acute kidney injury on distant organ function: recent findings and potential therapeutic targetsKidney International, 2016
- Mechanisms and mediators of lung injury after acute kidney injuryNature Reviews Nephrology, 2015
- The Uremic Toxicity of Indoxyl Sulfate and p-Cresyl SulfateJournal of the American Society of Nephrology, 2014
- Causes and treatment of oedema in patients with heart failureNature Reviews Cardiology, 2013
- Neutrophil Elastase Contributes to Acute Lung Injury Induced by Bilateral NephrectomyThe American Journal of Pathology, 2010
- Compartmentalization of neutrophils in the kidney and lung following acute ischemic kidney injuryKidney International, 2009
- Interleukin-6 mediates lung injury following ischemic acute kidney injury or bilateral nephrectomyKidney International, 2008
- Acute renal failure leads to dysregulation of lung salt and water channelsKidney International, 2003
- Renal ischemia/reperfusion leads to macrophage-mediated increase in pulmonary vascular permeabilityKidney International, 1999